Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

October 3, 2024

Study Completion Date

March 30, 2026

Conditions

Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8

Interventions

DRUG

Apalutamide

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Radical Prostatectomy

Undergo radical prostatectomy

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03412396 - Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy | Biotech Hunter | Biotech Hunter